HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 4.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 114,886 shares of the company's stock after acquiring an additional 5,080 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.13% of HealthEquity worth $11,023,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Arcadia Investment Management Corp MI acquired a new position in shares of HealthEquity during the 4th quarter worth approximately $26,000. Transce3nd LLC purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $29,000. Smartleaf Asset Management LLC increased its position in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $39,000. Finally, UMB Bank n.a. increased its position in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after purchasing an additional 164 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HQY. The Goldman Sachs Group dropped their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. KeyCorp dropped their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $111.75.

HealthEquity Stock Up 3.7%

HQY stock traded up $3.58 during mid-day trading on Tuesday, reaching $101.18. The company had a trading volume of 1,142,791 shares, compared to its average volume of 796,198. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market capitalization of $8.75 billion, a price-to-earnings ratio of 92.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The firm has a fifty day simple moving average of $87.92 and a 200 day simple moving average of $97.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This trade represents a 13.55% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.